Bullous Keratopathy Market is set to Grow at a Remarkable Pace by 2033
The global bullous keratopathy market is expected to register a CAGR of 4.3% from 2023 to 2033, reaching a valuation of US$ 427.54 Million in 2023, as per a recently published Future Market Insights report. The rising prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor propelling the industry's growth. According to the NCBI report, approximately 10-15% of patients diagnosed with keratoconus require to undergo a corneal implant procedure at some point. Corneal blindness is the third-leading cause of blindness after glaucoma and cataract affecting 10 million people globally. The most common cause of damage to endothelium layer of the cornea is eye surgery. Any kind of trauma, glaucoma, or inflammation from eye surgery can result in bullous keratopathy. Bullous keratopathy may occur in around 1% to 2% of patients undergoing cataract surgery, a nonsignificant number when you consider that approximately 10 million pati...